Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX) announced today that they received conditional authorization from European regulators.
The European Commission confirmed that it granted a conditional marketing authorization for the vaccine developed by the two companies, making it the first available COVID-19 vaccine in the European Union.
The news follows an earlier announcement that the companies had received a positive opinion from European regulators on their COVID-19 vaccine.
Get the full story at our sister site, Drug Discovery & Development.
